Prof. Hacer DURMUŞ TEKÇE

Metrics

Publication

161

Publication (WoS)

142

Publication (Scopus)

Citation (WoS)

901

H-Index (WoS)

Citation (Scopus)

1068

H-Index (Scopus)

Citation (Scholar)

257

H-Index (Scholar)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education

2016 - 2020

Undergraduate

Istanbul University, Open and Dıstance Educatıon Faculty, Open Education Programs, Turkey

2006 - 2010

Expertise In Medicine

Istanbul University, Nöroloji, Turkey

2000 - 2006

Doctorate

Hacettepe University, Tıp Fakültesi, Turkey

Dissertations

2010

Expertise In Medicine

Okülofaringodistal Miyopatinin Klinik ve Genetik Özelliklerinin Belirlenmesi

Istanbul University, Nöroloji Anabilim Dalı, Nöromüsküler Hastalıklar Bilim Dalı

Foreign Languages

B2 Upper Intermediate

German

Research Areas

Medicine

Health Sciences

Internal Medicine Sciences

Neurology

Academic Positions

2021 - Present

Professor

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

2015 - 2021

Associate Professor

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

2009 - 2009

Research Assistant

Newcastle College

Non Academic Experience

2011 - 2012

Uzman Doktor

Başkale Devlet Hastanesi, Uzman Doktor

Articles

2025

1. Kyphoscoliosis peptidase deficiency-induced myofibrillar degeneration, focal depletion of mitochondria, and protein aggregation: A true myofibrillar myopathy?

DURMUŞ TEKÇE H., Clemen C. S., ÖNAY UÇAR E., Hofmann A., Schlotzer-Schrehardt U., MERTOĞLU KAMALI E., et al.

JOURNAL OF NEUROMUSCULAR DISEASES , 2025 (SCI-Expanded, Scopus)

2025

2. Eculizumab as a Rescue Therapy in Prolonged Myasthenic Crisis in the Intensive Care Unit: A Case Series

Durmus H., Çakar A., Gülşen Parman Y.

Neurocritical Care , vol.42, no.3, pp.1099-1101, 2025 (SCI-Expanded)

2025

3. Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension

Adams D., Wixner J., Polydefkis M., Berk J. L., Conceição I. M., Dispenzieri A., et al.

JAMA Neurology , vol.82, no.3, pp.228-236, 2025 (SCI-Expanded)

2024

4. Current insights in ultra-rare adenylosuccinate synthetase 1 myopathy – meeting report on the First Clinical and Scientific Conference. 3 June 2024, National Centre for Advancing Translational Science, Rockville, Maryland, the United States of America

Rybalka E., Park H. J., Nalini A., Baskar D., Polavarapu K., Durmus H., et al.

Orphanet Journal of Rare Diseases , vol.19, no.1, 2024 (SCI-Expanded)

2024

5. Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis

Altınönder İ., Kaya M., Yentür S. P., Çakar A., Durmuş H., Yegen G., et al.

Journal of Neuroinflammation , vol.21, no.1, 2024 (SCI-Expanded)

2024

6. Eculizumab Versus Rituximab for Refractory Antiacetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: A Single-Center Experience

DURMUŞ TEKÇE H., ÇAKAR A., Parman Y. G.

ACTA NEUROLOGICA SCANDINAVICA , vol.2024, 2024 (SCI-Expanded)

2024

7. In vitro modulation of T cells in myasthenia gravis by low-dose IL-2

Çebi M., Çakar A., Durmuş H., Akan O., Aysal F., Parman Y., et al.

European Journal of Immunology , vol.54, no.11, 2024 (SCI-Expanded)

2024

8. Detection of gene variants associated with recessive limb–girdle muscular weakness and Pompe disease in a global cohort of patients through the application of next-generation sequencing analysis

Bevilacqua J. A., Al-Salti A. M., Al Madani A., Alves da Fonseca A., Durmus H., Chai J., et al.

Frontiers in Genetics , vol.15, 2024 (SCI-Expanded)

2024

9. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes

Ozdag Acarli A. N., Tuzun E., Sanli E., Koral G., Akbayir E., Cakar A., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.215, no.1, pp.65-78, 2024 (SCI-Expanded)

2023

10. Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation

Karazi W., Scalco R. S., Stemmerik M. G., Løkken N., Lucia A., Santalla A., et al.

Orphanet Journal of Rare Diseases , vol.18, no.1, 2023 (SCI-Expanded)

2023

11. Phenotypic features of RETREG1-related hereditary sensory autonomic neuropathy

Çakar A., Bagırova G., Durmuş H., Uyguner O., Parman Y.

Journal of the Peripheral Nervous System , vol.28, no.3, pp.351-358, 2023 (SCI-Expanded)

2023

12. Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression

Cebi M., Cakar A., Erdogdu E., Durmus-Tekce H., Yegen G., Ozkan B., et al.

JOURNAL OF NEUROIMMUNOLOGY , 2023 (SCI-Expanded)

2023

13. Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective

ERDEM ÖZDAMAR S., KOÇ A. F., Durmus Tekce H., Kotan D., Ekmekci A. H., ŞENGÜN İ. Ş., et al.

Frontiers in Neurology , vol.14, 2023 (SCI-Expanded)

2023

14. A novel homozygous loss-of-function variant in SOD1 causing progressive spastic tetraplegia and axial hypotonia

Çakar A., Pekbilir E., CEYLANER S., Durmuş H., Battaloğlu E., Şahin U., et al.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration , vol.24, no.5-6, pp.535-538, 2023 (SCI-Expanded)

2022

15. Disease activity in chronic inflammatory demyelinating polyneuropathy: A comparative study of clinical and skin biopsy markers

Acarli A. N. O., Unverengil G., Sirin N. G., Cakar A., Durmus H., Parman Y.

MUSCLE & NERVE , vol.66, no.6, pp.736-743, 2022 (SCI-Expanded)

2022

16. Desmin Knock-Out Cardiomyopathy: A Heart on the Verge of Metabolic Crisis

Elsnicova B., Hornikova D., Tibenska V., Kolar D., Tlapakova T., Schmid B., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.23, no.19, 2022 (SCI-Expanded)

2022

17. Investigation of a Novel Recessive Mutation in Acetylcholine Receptor Epsilon-Subunit with Slow-Channel Kinetics Causing Congenital Myasthenia Reveals Subunit-Specific Contribution of Cys-Loop Length to Receptor Activation

Shen X., Shen S., Zhao Y., Di L., Durmus H., Deymeer F., et al.

ANNALS OF NEUROLOGY , vol.92, 2022 (SCI-Expanded)

2022

18. Clinical and genetic characteristics of Emery-Dreifuss muscular dystrophy patients from Turkey: 30 years longitudinal follow-up study.

Yunisova G., CEYLANER S., Oflazer P., Deymeer F., Parman Y. G., Durmus H.

Neuromuscular disorders : NMD , vol.32, no.9, pp.718-727, 2022 (SCI-Expanded)

2022

19. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (canvas): an important cause of late-onset ataxia with unique clinical features

ÇAKAR A., Sahin E., Tezel S., Candayan A., Samanci B., BATTALOĞLU E., et al.

ACTA NEUROLOGICA BELGICA , vol.122, no.4, pp.939-945, 2022 (SCI-Expanded)

2022

20. AN EXPLORATORY STUDY OF COGNITIVE INVOLVEMENT IN HEREDITARY ATTRV

Durmus H., Cakar A., Demirci H., Parman Y.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.27, 2022 (SCI-Expanded)

2022

21. Phenotypical spectrum of SACS variants: Neuromuscular perspective of a complex neurodegenerative disorder

Cakar A., Inci M., Acarli A. N. O., Comu S., Candayan A., BATTALOĞLU E., et al.

ACTA NEUROLOGICA SCANDINAVICA , vol.145, pp.619-626, 2022 (SCI-Expanded)

2022

22. Lumbar Spinal Stenosis: A Rare Presentation of Hereditary Transthyretin Amyloidosis

Cakar A., Atmaca M. M., Kotan D., Durmus H., Deymeer F., Oflazer P., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.59, no.1, pp.77-79, 2022 (SCI-Expanded)

2021

23. An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis

Durmus H., Cakar A., Demirci H., ALAYLIOĞLU M., GEZEN AK D., DURSUN E., et al.

ACTA NEUROLOGICA SCANDINAVICA , vol.144, no.6, pp.640-646, 2021 (SCI-Expanded)

2021

24. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine

Durmus H., Sticht H., Ceylaner S., Hashemolhosseini S., Deymeer F.

ACTA NEUROLOGICA BELGICA , vol.121, no.6, pp.1755-1760, 2021 (SCI-Expanded)

2021

25. Genetic Survey of Autosomal Recessive Peripheral Neuropathy Cases Unravels High Genetic Heterogeneity in a Turkish Cohort

Candayan A., Çakar A., Yunisova G., Özdağ Acarlı A. N., Atkinson D., Topaloğlu P., et al.

NEUROLOGY-GENETICS , vol.7, no.5, 2021 (SCI-Expanded)

2021

26. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (Canvas) is an important cause of late-onset ataxia

Cakar A., Sahin E., Tezel S., Candayan A., Samanci B., BATTALOĞLU E., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3, pp.364, 2021 (SCI-Expanded)

2021

27. Episodic psychosis, ataxia, motor neuropathy with pyramidal signs (PAMP sydrome) caused by a novel mutation in ADPRHL2 (AHR3)

Durmus H., Mertoglu E., Sticht H., Ceylaner S., Kulaksizoglu I. B., Hashemolhosseini S., et al.

NEUROLOGICAL SCIENCES , vol.42, no.9, pp.3871-3878, 2021 (SCI-Expanded, Scopus)

2021

28. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.

MOVEMENT DISORDERS , vol.36, pp.1676-1688, 2021 (SCI-Expanded)

2021

29. Diaphragmatic dysfunction at the first visit to a chest diseases outpatient clinic in 500 patients with amyotrophic lateral sclerosis

Pihtili A., Bingol Z., Durmus H., Parman Y., Kiyan E.

MUSCLE & NERVE , vol.63, pp.683-689, 2021 (SCI-Expanded)

2021

30. SOD1 Mutation: A Single Center Experience

ÇAKAR A., DURMUŞ TEKÇE H., PARMAN F. Y.

NEUROLOGY , no.15, 2021 (SCI-Expanded)

2021

31. Late-onset TK2-Deficiency Patients from Turkey

DURMUŞ TEKÇE H., ÇAKAR A., PARMAN F. Y.

NEUROLOGY , no.15, 2021 (SCI-Expanded)

2021

32. Genotypic and phenotypic features of mutations in the HINT1 gene among Turkish patients with hereditary axonal neuropathy

Acarli A. O., Cakar A., Candayan A., Durmus H., Ceylaner S., Matur Z., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.1, pp.124-125, 2021 (SCI-Expanded)

2020

33. Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)

Scalco R. S., Lucia A., Santalla A., Martinuzzi A., Vavla M., Reni G., et al.

ORPHANET JOURNAL OF RARE DISEASES , vol.15, no.1, 2020 (SCI-Expanded)

2020

34. Cognition of the mothers of patients with Duchenne muscular dystrophy.

Demirci H., Durmus H., Toksoy G., Uslu A., Parman Y., Hanagasi H. A.

Muscle & nerve , vol.62, no.6, pp.710-716, 2020 (SCI-Expanded, Scopus)

2020

35. The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients

YILMAZ V., TÜZÜN E., DURMUŞ TEKÇE H., Oflazer P., Aysal F., Parman Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.349, 2020 (SCI-Expanded)

2020

36. Correlations between radiographic spinopelvic parameters and health-related quality of life: A prospective evaluation of 37 patients with facioscapulohumeral muscular dystrophy

Bayram S., Kendirci A. Ş., Karalar Ş., Durmuş Tekçe H., Parman F. Y., Akgül T., et al.

Clinical Neurology and Neurosurgery , vol.198, 2020 (SCI-Expanded)

2020

37. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

Toepf A., Johnson K., Bates A., Phillips L., Chao K. R., England E. M., et al.

GENETICS IN MEDICINE , vol.22, no.9, pp.1478-1488, 2020 (SCI-Expanded)

2020

38. Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database

Tunca C., Seker T., Akcimen F., Coskun C., Bayraktar E., Palvadeau R., et al.

HUMAN MUTATION , vol.41, no.8, 2020 (SCI-Expanded)

2020

39. Four Individuals with a Homozygous Mutation in Exon 1f of thePLECGene and Associated Myasthenic Features

Mroczek M., DURMUŞ TEKÇE H., Topf A., Parman Y., Straub V.

GENES , vol.11, no.7, 2020 (SCI-Expanded)

2020

40. EVALUATION OF REPETITIVE NERVE STIMULATION WITH DIFFERENT STIMULATION FREQUENCIES IN PATIENTS WITH MYASTHENIA GRAVIS

Sirin N. G., KOCASOY ORHAN E., Oguz Akarsu E., DURMUŞ TEKÇE H., Deymeer F., BASLO M. B.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.83, no.3, pp.197-203, 2020 (ESCI)

2020

41. CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS

Cebi M., DURMUŞ TEKÇE H., Aysal F., ÖZKAN B., Gul G. E., ÇAKAR A., et al.

Frontiers in Immunology , vol.11, 2020 (SCI-Expanded)

2020

42. Expanding the disease phenotype of ADSSL1-associated myopathy in non-Korean patients

Mroczek M., DURMUŞ TEKÇE H., Bijarnia-Mahay S., Topf A., Ghaoui R., Bryen S., et al.

NEUROMUSCULAR DISORDERS , vol.30, no.4, pp.310-314, 2020 (SCI-Expanded)

2020

43. Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome

Yildiz Celik S., DURMUŞ TEKÇE H., YILMAZ V., SARUHAN DİRESKENELİ G., Gulsen Parman Y., Serdaroglu Oflazer P., et al.

ACTA NEUROLOGICA BELGICA , vol.120, no.1, pp.133-140, 2020 (SCI-Expanded)

2019

44. A Val30Met sporadic familial amyloid polyneuropathy case with atypical presentation: upper limb onset of symptoms

Sahin E., Cakar A., Durmus-Tekce H., Parman Y.

ACTA NEUROLOGICA BELGICA , vol.119, no.4, pp.627-628, 2019 (SCI-Expanded)

2019

45. A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID.

Akcimen F., Vural A., Durmus H., Cakar A., Houlden H., Parman Y. G., et al.

Journal of human genetics , vol.64, no.11, pp.1141-1144, 2019 (SCI-Expanded)

2019

46. The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-Tooth-like phenotype

Candayan A., Yunisova G., Cakar A., Durmus H., Basak A. N., Parman Y., et al.

NEUROGENETICS , 2019 (SCI-Expanded)

2019

47. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).

ÇEBI M., DURMUŞ H., YILMAZ V., YENTÜR S. P., AYSAL F., OFLAZER P., et al.

Clinical and experimental immunology , vol.197, pp.214-221, 2019 (SCI-Expanded)

2019

48. Mutation spectrum of 260 dystrophinopathy patients from Turkey and important highlights for genetic counseling

Toksoy G., Durmus H., Aghayev A., Bagirova G., Rustemoglu B. S., Basaran S., et al.

NEUROMUSCULAR DISORDERS , no.8, pp.601-613, 2019 (SCI-Expanded)

2019

49. Familial Amyloid Polyneuropathy

Cakar A., Durmus-Tekce H., Parman Y.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.56, no.2, pp.150-156, 2019 (SCI-Expanded)

2019

50. Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population

Johnson K., De Ridder W., Topf A., Bertoli M., Phillips L., De Jonghe P., et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , vol.90, no.4, pp.490-493, 2019 (SCI-Expanded)

2018

51. Repetitive nerve stimulation and jitter measurement with disposable concentric needle electrode in newly diagnosed myasthenia gravis patients

Sirin N. G., Orhan E., Durmus H., Deymeer F., Baslo M. B.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY , vol.48, no.5, pp.261-267, 2018 (SCI-Expanded)

2018

52. Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis

Hocaoglu M., Durmus H., Ozkan B., Yentur S. P., Dogan O., Parman Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.323, pp.36-42, 2018 (SCI-Expanded)

2018

53. Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness

Johnson K., Bertoli M., Phillips L., Topf A., Van den Bergh P., Vissing J., et al.

SKELETAL MUSCLE , vol.8, 2018 (SCI-Expanded)

2018

54. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up

Durmus H., SHEN X., Serdaroglu-Oflazer P., Kara B., Parman-Gulsen Y., Ozdemir C., et al.

NEUROMUSCULAR DISORDERS , vol.28, no.4, pp.315-322, 2018 (SCI-Expanded)

2018

55. A database for screening and registering late onset Pompe disease in Turkey

GOKYIGIT M. C., Ekmekci H., Durmus H., Karll N., Koseoglu E., AYSAL F., et al.

NEUROMUSCULAR DISORDERS , vol.28, no.3, pp.262-267, 2018 (SCI-Expanded)

2018

56. Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor epsilon-subunit

SHEN X., BRENGMAN J. M., SHEN S., Durmus H., PREETHISH-KUMAR V., Yuceyar N., et al.

JCI INSIGHT , vol.3, no.2, 2018 (SCI-Expanded)

2017

57. Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease

Inal-Gultekin G., Toptas-Hekimoglu B., Gormez Z., Gelisin O., Durmus H., ERGUNER B., et al.

NEUROMUSCULAR DISORDERS , vol.27, no.11, pp.997-1008, 2017 (SCI-Expanded, Scopus)

2017

58. Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

Giris M., Durmus H., Yetimler B., Tasli H., Parman Y., Tuzun E.

IN VIVO , no.4, pp.657-660, 2017 (SCI-Expanded)

2017

59. MUSCLE MAGNETIC RESONANCE IMAGING IN SPINAL MUSCULAR ATROPHY TYPE 3: SELECTIVE AND PROGRESSIVE INVOLVEMENT

Durmus H., Yilmaz R. S., Gulsen-Parman Y., Oflazer-Serdaroglu P., CUTTINI M., Dursun M., et al.

MUSCLE & NERVE , vol.55, no.5, pp.651-656, 2017 (SCI-Expanded)

2017

60. Jitter measurement using a concentric needle in 133 patients with myasthenia gravis: A retrospective analysis

Sirin N. G., Orhan E. K., Durmus H., Oflazer P., Parman Y., Oge A. E., et al.

Journal of Neurological Sciences , vol.34, no.3, pp.207-214, 2017 (SCI-Expanded)

2016

61. Neuromuscular endplate pathology in recessive desminopathies: Lessons from man and mice

Durmus H., Ayhan O., CIRAK S., Deymeer F., Parman Y., FRANKE A., et al.

NEUROLOGY , no.8, pp.799-805, 2016 (SCI-Expanded)

2016

62. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.

Durmus-Tekce H., MATUR Z., Atmaca M. M., Poda M., Cakar A., ULAS U. H., et al.

Neuromuscular disorders : NMD , vol.26, no.7, pp.441-6, 2016 (SCI-Expanded)

2016

63. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.

Saruhan-Direskeneli G., HUGHES T., Yilmaz V., Durmus H., ADLER A., Alahgholi-Hajibehzad M., et al.

Clinical immunology (Orlando, Fla.) , pp.81-8, 2016 (SCI-Expanded)

2016

64. Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.

Stergiou C., Lazaridis K., Zouvelou V., Tzartos J., Mantegazza R., Antozzi C., et al.

Journal of neuroimmunology , vol.292, pp.108-15, 2016 (SCI-Expanded)

2016

65. Myasthenia gravis after botulinum toxin type A injection Botulinum toksin tip A enjeksiyonu sonrası açığa çıkan myasthenia gravis olgusu

Tekce H., Deymeer F., Serdaroglu P. O., Parman Y.

Turk Noroloji Dergisi , vol.22, no.3, pp.143-144, 2016 (Scopus)

2016

66. Vocal Cord Paralysis and Hypercapnic Respiratory Failure in a Patient with Familial Amyloidotic Polyneuropathy

PIHTILI A., Bingol Z., Durmus H., Parman Y., Kiyan E.

INTERNAL MEDICINE , no.13, pp.1783-1786, 2016 (SCI-Expanded)

2015

67. Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice.

Ozkok E., Durmus H., Yetimler B., Tasli H., TRAKAS N., Ulusoy C. A., et al.

Clinical neuropathology , vol.34, no.6, pp.359-63, 2015 (SCI-Expanded)

2015

68. MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.

Tsonis A. I., Zisimopoulou P., Lazaridis K., Tzartos J., Matsigkou E., Zouvelou V., et al.

Journal of neuroimmunology , vol.284, pp.10-7, 2015 (SCI-Expanded)

2015

69. Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK

Yilmaz V., Oflazer P., AYSAL F., Durmus H., Poulas K., Yentur S. P., et al.

PLoS ONE , vol.10, no.4, 2015 (SCI-Expanded)

2015

70. Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.

Alahgholi-Hajibehzad M., Oflazer P., Aysal F., Durmus H., Gulsen-Parman Y., MARX A., et al.

Journal of neuroimmunology , vol.281, pp.51-60, 2015 (SCI-Expanded)

2015

71. The distinct genetic pattern of ALS in Turkey and novel mutations

Ozoguz A., Uyan O., Birdal G., Iskender C., Kartal E., Lahut S., et al.

Neurobiology of Aging , vol.36, no.4, 2015 (SCI-Expanded)

2015

72. Prevalence of Parkinson's disease in Baskale, Turkey: a population based study

Durmus H., Gökalp M. A., Hanagasi H. A.

NEUROLOGICAL SCIENCES , vol.36, no.3, pp.411-413, 2015 (SCI-Expanded)

2014

73. Association between restless leg syndrom and slow coronary flow

ERDEN I., ERDEN E. C., Durmus H., Tibilli H., TABAKCI M., KALKAN M. E., et al.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , vol.14, no.7, pp.612-616, 2014 (SCI-Expanded)

2014

74. Facial and Skeletal Muscle Magnetic Resonance Imaging in Oculopharyngodistal Myopathy

DURMUŞ TEKÇE H., Dursun M., Sencer S., Deymeer F., Oflazer-Serdaroglu P.

TURKISH JOURNAL OF NEUROLOGY , vol.20, no.4, pp.121-125, 2014 (ESCI)

2014

75. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

ZISIMOPOULOU P., EVANGELAKOU P., TZARTOS J., LAZARIDIS K., ZOUVELOU V., MANTEGAZZA R., et al.

Journal of Autoimmunity , vol.52, pp.139-145, 2014 (SCI-Expanded)

2013

76. Prevalence of Parkinson's disease in Baskale, Turkey: A population-based study

Durmus H., Gokalp M. A., Hanagasi H. A.

MOVEMENT DISORDERS , vol.28, 2013 (SCI-Expanded)

2013

77. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures

Durmus H., Kurtuncu M., Tuzun E., Pehlivan M., Akman-Demir G., Yapici Z., et al.

Acta Neurologica Belgica , vol.113, no.4, pp.421-426, 2013 (SCI-Expanded)

2011

78. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis

Tuzun E., Erdag E., Durmus H., Brenner T., Turkoglu R., Kurtuncu M., et al.

NEUROLOGY INDIA , vol.59, no.1, pp.47-50, 2011 (SCI-Expanded)

2010

79. SLEEP RELATED BREATHING DISORDERS AND LUNG FUNCTION IN PATIENTS WITH OCULOPHARYNGODISTAL MYOPATHY

Memis U., Kiyan E., Durmus H., Oflazer P.

RESPIROLOGY , vol.15, pp.106, 2010 (SCI-Expanded)

2010

80. Unihemispheric acute disseminated encephalomyelitis: A case report Tek hemisferi tutan akut dissemine ensefalomiyelit: Olgu sunumu

Durmus H., TURKOGLU R., Tuzun E.

Noropsikiyatri Arsivi , vol.47, no.2, pp.166-168, 2010 (SCI-Expanded)

2010

81. Amphiphysin Autoimmunity: Associated Neurological Syndromes and Tumors in The Turkish Population

Tuzun E., Bebek N., Icoz S., Durmus H., Kurtuncu M., Gurses C., et al.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , vol.27, no.2, pp.121-126, 2010 (SCI-Expanded)

2010

82. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations

Schara U., Christen H., Durmus H., Hietala M., Krabetz K., Rodolico C., et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.14, no.4, pp.326-333, 2010 (SCI-Expanded)

2010

83. Sensorimotor neuropathy associated with endometrioid endometrial carcinoma

Durmus H., Tuzun E., Icoz S., Akman-Demir G., Parman Y.

European Journal of Obstetrics and Gynecology and Reproductive Biology , vol.150, no.2, pp.216-217, 2010 (SCI-Expanded)

2010

84. Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients

Icoz S., Tuzun E., Kurtuncu M., Durmus H., Mutlu M., Eraksoy M., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , no.1, pp.71-75, 2010 (SCI-Expanded)

2009

85. Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids

Kurtuncu M., Tuzun E., Durmus H., Mutlu M., Akman-Demir G., Eraksoy M.

Leukemia and Lymphoma , vol.50, no.9, pp.1552-1553, 2009 (SCI-Expanded)

2009

86. Antinuclear antibodies in juvenile myoclonic epilepsy

Altindag E., Icoz S., Tuzun E., Durmus H., Uludokumaci A., Demir G. A., et al.

Journal of Neurological Sciences , vol.26, no.1, pp.43-48, 2009 (Scopus)

2009

87. Pregnancy-Induced Atypic Demyelinating Inflammatory Disease

Durmus H., Tuzun E., Kurtuncu M., Mutlu M., Demir G. A., Eraksoy M.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , no.2, pp.80-83, 2009 (SCI-Expanded)

2009

88. Development of multiple sclerosis in patients with optic neuritis: Analysis of predictive factors

Durmuş Tekçe H., Kürtüncü M., Tüzün E., Akalın B. E., Mutlu M., Akman Demir G., et al.

TURK NOROLOJI DERGISI , vol.15, no.3, pp.119-123, 2009 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences

2024

1. GENETIC LANDSCAPE OF CHARCOT-MARIE-TOOTH DISEASE IN TURKIYE: DISTINCT DISTRIBUTION, RARE PHENOTYPES, AND NOVEL VARIANTS

Çakar A., Candayan A., Bagirova G., Uyguner Z. O., Ceylaner S., Durmuş Tekçe H., et al.

Annual Meeting of the Peripheral-Nerve-Society (PNS), Montreal, Canada, 22 - 25 June 2024, vol.29, pp.11, (Summary Text)

2022

2. Long-term follow-up of five families from Turkey with UBQLN2 variants

Durmus H., ÇAKAR A., Aysal F., Ertas M., Basak N., Parman Y.

21st Annual Meeting of the Northeast-Amyotrophic-Lateral-Sclerosis-Consortium (NEALS), Florida, United States Of America, 1 - 03 November 2022, (Summary Text)

2022

3. Correlations Between Radiographic Spinopelvic Parameters And Health-Related Quality Of Life: A Prospective Evaluation Of 37 Patients With Facioscapulohumeral Muscular Dystrophy

BAYRAM S., KENDİRCİ A. Ş., KARALAR Ş., DURMUŞ TEKÇE H., PARMAN F. Y., AKGÜL T., et al.

23nd EFORT Congress, Lisbon, Portugal, 22 - 24 June 2022, vol.23, (Full Text)

2022

4. GNE miyopatisinde solunumsal problemler

Dikmen B., Pıhtılı A., Kıyan E., Parman F. Y., Durmuş Tekçe H.

Türk Toraks Derneği 25. Yıllık Kongresi, Antalya, Turkey, 24 - 28 May 2022, pp.896, (Summary Text)

2022

5. An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis

Durmus H., ÇAKAR A., Demirci H., Parman F. Y.

Annual Meeting of the American-Academy-of-Neurology, Washington, United States Of America, 2 - 07 April 2022, (Summary Text)

2021

6. YAYGIN HİPERPİGMENTASYON İLE BAŞVURAN BİR DERMATOMİYOZİT OLGUSU

GEZEGEN H., ALTINKAYNAK M., ÇAKAR A., DURMUŞ TEKÇE H., AKPINAR T. S., PARMAN F. Y.

57. Ulusal nöroloji kongresi, Antalya, Turkey, 27 November 2021, (Summary Text)

2021

7. Clinical and Electrophysiological Characteristics of Guillain-Barré Syndrome Before and During the Pandemic: Multicenter Istanbul Study

Taşdemir V., Şirin İnan N. G., Çakar A., Çulha A., Soysal A., Elmalı Yazıcı A. D., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Unpublished)

2021

8. Effects of immunosuppressive treatment on thymocyte maturation in Myasthenia Gravis patiens

Yentür S. P., Durmuş Tekçe H., Erdoğdu E., Yegen G., Yılmaz V., Özkan B., et al.

European Congress of Immunology, Belgrade, Serbia, 1 - 04 September 2021, pp.78, (Summary Text)

2021

9. Expanding the phenotypical spectrum of SACS mutation: A Single Center Experience

ÇAKAR A., İNCİ M., ÖZDAĞ ACARLI A. N., DURMUŞ TEKÇE H., PARMAN F. Y.

Virtual Annual Meeting of the American-Academy-of-Neurology, ELECTR NETWORK, 17 - 22 April 2021, (Summary Text)

2021

10. Cognitive involvement in transthyretin-related familial amyloid polyneuropathy (TTR-FAP)

DURMUŞ TEKÇE H., ÇAKAR A., Demirci H., PARMAN F. Y.

Virtual Annual Meeting of the American-Academy-of-Neurology, ELECTR NETWORK, 17 - 22 April 2021, (Summary Text)

2020

11. Cognitive involvement in ATTR amyloidosis (TTR-FAP)

DURMUŞ TEKÇE H., ÇAKAR A., Demirci H., Alaylioglu M., GEZEN AK D., DURSUN E., et al.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 January 2020, pp.527, (Summary Text)

2020

12. Clinical features of a homozygous missense mutation in the FXN gene resulting in a Charcot-Marie-Tooth-like phenotype

ÇAKAR A., Candayan A., Yunisova G., Battaloglu E., DURMUŞ TEKÇE H., PARMAN F. Y.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 January 2020, pp.490, (Summary Text)

2020

13. Episodic psychosis, ataxia, motor neuropathy caused by a novel mutation in ADPRHL2

DURMUŞ TEKÇE H., Hashemolhosseini S., CEYLANER S., PARMAN F. Y.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 January 2020, pp.558, (Summary Text)

2020

14. 3 individuals with mutation in exon 1f of PLEC and myasthenic phenotype

Mroczek M., Durmus H., Topf A., Duff J., Parman Y., Straub V.

6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 May 2020, vol.27, pp.1151, (Summary Text)

2020

15. Clinical And Genetic Characteristics of Bethlem Myopathy Patients from Turkey

Yunisova G., Ceylaner S., Deymeer F., Oflazer P., Durmus H., Parman Y.

6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 May 2020, vol.27, pp.1158, (Summary Text)

2020

16. EPISODIC PSYCHOSIS, ATAXIA, MOTOR NEUROPATHY CAUSED BY A NOVEL MUTATION IN ADPRHL2

DURMUŞ TEKÇE H., Sticht H., Ceylaner S., Hashemolhosseini S., Parmn Y.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

2020

17. Circulating B Cell Subsets and Cytokine Gene Expression Levels in Peripheral Blood and Skin Biopsy in Chronic Inflammatory Demyelinating Polyneuropathy

Acarli A. N. O., Yilmaz V., Sirin N. G., ÇAKAR A., Soysal A., Aysal F., et al.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, (Summary Text)

2020

18. Clinical and genetic features of SPG11: A Single Center Experience

Cakar A., Gezegen H., Tunca C., Bayraktar E., Basak N., Durmus-Tekce H., et al.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

2020

19. Studying Clinical and Genetic Characteristics of Emery-Dreifuss Muscular Dystrophy

Yunisova G., Oflazer P., Deymeer F., ÇAKAR A., PARMAN F. Y., DURMUŞ TEKÇE H.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

2020

20. Skin Biopsy as a Biomarker in Chronic Inflammatory Demyelinating Polyneuropathy

Parman Y., Acarli A. N. O., ÜNVERENGİL G., Sirin N. G., ÇAKAR A., DURMUŞ TEKÇE H.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, (Summary Text)

2019

21. Antibodies Against Peripheral Nerve Antigens in Chronic Inflammatory Demyelinating Polyradiculoneuropathy in a Turkish Cohort

ÖZDAĞ ACARLI A. N., VURAL A., YILMAZ V., Şirin N., DURMUŞ TEKÇE H., SARUHAN DİRESKENELİ G., et al.

2019 PNS (Peripheral Nerve Society) Annual Meeting, Cenova, Italy, 21 - 26 June 2019

2019

22. GNE MYOPATHY in TURKEY: CLINICAL FEATURES AND NOVEL MUTATIONS

Durmus H., Ceylaner S., Parman F. Y., Deymeer F., Serdaroglu P.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)

2019

23. Autosomal Recessive Charcot-Marie-Tooth Disease in Turkey

Parman Y., Cakar A., Candayan A., Akcay H. I., Yunisova G., Ulukan Ç., et al.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)

2018

24. Congenital myasthenic syndromes due to impaired principal coupling pathway in the epsilon-subunit of muscle acetylcholine receptor

Shen X., Selcen D., Brengman J., Shen S., Durmus H., Preethish-Kumar V., et al.

23rd International Annual Congress of the World-Muscle-Society (WMS), Mendoza, Argentina, 2 - 06 October 2018, vol.28, (Summary Text)

2018

25. Clinical and Genetic Features in X-Linked Charcot-Marie-Tooth Neuropathy (CMT-X) Patients from Turkey

Parman Y., Durmus H., Candayan A., Akcay H. I., Yunisova G., Ulukan Ç., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

2018

26. Congenital Myasthenic Syndromes (CMS) Due to Impaired Principal Coupling Pathway in the. Subunit of Muscle Acetylcholine Receptor (AChR)

Shen X., Brengman J., Shen S., Durmus H., Preethish-Kumar V., Yuceyar N., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

2018

27. Klinik Fasilitasyonun Eşlik Ettiği Myasthenia Gravis: Olgu Serisi

ATMACA M. M., DURMUŞ TEKÇE H., KOCASOY ORHAN E., BASLO M. B., DEYMEER F.

34.Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Turkey, 4 - 08 April 2018

2017

28. GENOTYPIC AND PHENOTYPIC PRESENTATION OF TRANSTHYRETIN- RELATED FAMILIAL AMYLOID POLYNEUROPATHY (TTR-FAP) IN TURKEY

Durmus H., Cakar A., Sahin E., Matur Z., Poda M., Altunoglu U., et al.

Peripheral-Nerve-Society Meeting, Sitges, Spain, 8 - 12 July 2017, vol.22, pp.276-277, (Summary Text)

2017

29. Congenital myasthenic syndromes in Turkey

Durmus H., Kara B., Parman Y., Oflazer P., Deymeer F.

3rd Congress of the European-Academy-of-Neurology, Amsterdam, Netherlands, 01 June 2017, vol.24, pp.500, (Summary Text)

2016

30. PAROKSİSMAL DİZARTRİ VE ATAKSİ ATAKLARIYLA BAŞVURAN LEPTOMENİNGEAL TUTULUMLA GİDEN MEME KANSERİ OLGUSU

Uygun Ö., Sezgin M., Durmuş Tekçe H., Baykan B.

52. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Turkey, 25 November - 01 December 2016, pp.97-98, (Summary Text)

2016

31. CHARCOT-MARIE-TOOTH DISEASE IN TURKEY: CLINICAL AND GENETIC FINDINGS FROM A SINGLE-CENTRE EXPERIENCE

Akcay H., Durmus H., Deymeer F., Oflazer-Serdaroglu P., Sivaci M., Candayan A., et al.

Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and Ceilidh, Glasgow, United Kingdom, 21 - 24 June 2016, vol.21, pp.230-231, (Summary Text)

2016

32. Clinical and Genetic Heterogeneity in Charcot-Marie-Tooth Neuropathy Type 2 Patients from Turkey

Durmus H., Akcay H. I., Sivaci M., Serdaroglu P., Deymeer F., Battaloglu E., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)

2016

33. Clinical and Genetic Heterogeneity in Familial ALS Patients from Turkey

Durmus H., Sezgin M., Samanci B., Ozoguz A., Deymeer F., Serdaroglu P., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, (Summary Text)

2015

34. TÜRK TOPLUMUNDA EN SIK RASTLANILAN MİYOFOSFORİLAZ (PYGM) MUTASYONLARI: MCARDLE HASTALIĞININ GENETİK TANISI İÇİN YENİ NESİL DİZİLEME

İNAL GÜLTEKİN G., TOPTAŞ HEKİMOĞLU B., GÖRMEZ Z., DURMUŞ TEKÇE H., SAĞIROĞLU M. Ş., DEMİRCİ H., et al.

51. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 03 December 2015, (Summary Text)

2015

35. Genotypic and phenotypic presentation of Glu89Gln mutation in Turkey

DURMUŞ TEKÇE H., MATUR Z., ATMACA M. M., PODA M., ÇAKAR A., SERDAROĞLU OFLAZER P., et al.

First European Congress on Hereditary ATTR amyloidosis, France, 2 - 03 November 2015

2015

36. Evaluation of maximum oxygen utilization in McArdle patients before and after exercise training

Gelisin O., Durmus H., Yakal S., Kasikcioglu E., Parman Y., Deymeer F., et al.

20th International Congress of the World-Muscle-Society, Brighton, United Kingdom, 30 September - 04 October 2015, vol.25, (Summary Text)

2015

37. **Myophosphorylase (PYGM) mutations in Turkish patients with McArdle disease: A next generation sequencing study**

Gultekin G. I., Hekimoglu B. T., Gormez Z., Durmus H., Demirci H., Sagiroglu M., et al.

20th International Congress of the World-Muscle-Society, Brighton, England, 30 September - 04 October 2015, (Summary Text)

2015

38. **CLINICAL AND GENETIC CHARACTERISTICS OF 20 ALS PATIENTS FROM TURKEY WITH SOD1 MUTATIONS**

Samanci B., Durmus H., Ozoguz A., Oflazer-Serdaroglu P., Deymeer F., Basak A. N., et al.

Biennial Meeting of the Peripheral-Nerve-Society, Quebec, Canada, 27 June - 02 July 2015, pp.224-225, (Summary Text)

2015

39. GENETIC SURVEY OF A LARGE COHORT OF CMT PATIENTS FROM TURKEY REVEALED EQUAL FREQUENCIES OF CMT1A DUPLICATION AND HNPP DELETION

Ozes B., Sivaci M., Akyuz K., Durmus H., Deymeer F., Oflazoglu P., et al.

Biennial Meeting of the Peripheral-Nerve-Society, Quebec, Canada, 27 June - 02 July 2015, vol.20, pp.205, (Summary Text)

2015

40. Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice

Durmus H., Ozkok E., Yetimler B., Tuzun E.

1st Congress of the European-Academy-of-Neurology, Berlin, Germany, 20 - 23 June 2015, vol.22, pp.720

2015

41. Ocular myasthenia gravis

Uyar T., Durmus H., Parman Y., Serdaroglu-Oflazer P., Saruhan-Direskeneli G., Deymeer F.

1st Congress of the European-Academy-of-Neurology, Berlin, Germany, 20 - 23 June 2015, vol.22, pp.720, (Summary Text)

2015

42. Myasthenia gravis hastalarının elektrofizyolojik incelemelerine retrospektif bir bakış

ŞİRİN N. G., KOCASOY ORHAN E., DURMUŞ TEKÇE H., BASLO M. B., DEYMEER F.

31. ulusal klinik nörofizyoloji EEG-EMG kongresi, Turkey, 8 - 12 April 2015

2014

43. İ.T.F. NÖROLOJİ ANABİLİM DALINDA İZLENEN AMYOTROFİK LATERAL SKLEROZ HASTALARININ GENETİK VE KLİNİK ÖZELLİKLER AÇISINDAN İNCELENMESİ

Sezgin M., Samancı B., Durmuş Tekçe H., Özoğuz A., Oflazer Serdaoğlu P., Deymeer F., et al.

50. Ulusal Nöroloji Kongresi, Antalya, Turkey, 22 November - 26 December 2014, pp.90-91, (Summary Text)

2014

44. Differential cytokine changes in myasthenia gravis patients with antibodies against AChR and Musk

Yilmaz V., Oflazer P., Aysal F., Durmus H., Poulos K., Parman Y., et al.

12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.212-213, (Summary Text)

2014

45. Late-onset non-thymomatous generalized myasthenia gravis

Yildiz-Celik S., Durmus H., Hajibehzad M., Yilmaz V., Oflazer-Serdaroglu P., Parman Y., et al.

19th International Congress of the World-Muscle-Society, Berlin, Germany, 7 - 11 October 2014, vol.24, pp.842, (Summary Text)

2014

46. Dramatic improvement after injection augmentation in oculopharyngodistal myopathy

Ozcan O., Durmus H., Tarhan O., Polat Z., Deymeer F., Parman Y., et al.

19th International Congress of the World-Muscle-Society, Berlin, Germany, 7 - 11 October 2014, vol.24, pp.796, (Summary Text)

2014

47. Exome sequencing vs phenotype directed gene screening in CMT patients from Turkey

Sivaci M., Parman Y., Gonzaga-Jauregui C., Pehlivan D., Durmus H., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

2014

48. Clinical and genetic features of patients with MNGIE: cohort at the department of neurology, Istanbul Faculty of Medicine

Cakar A., Durmus H., Gunduz T., Deymeer F., Parman Y., Oflazer-Serdaroglu P.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.21, pp.519, (Summary Text)

2014

49. Genotypic and phenotypic presentation of TTR-FAP in Turkey

Durmus H., Matur Z., Atmaca M. M., PODA M., Oflazer-Serdaroglu P., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

2014

50. Exome sequencing vs. phenotype directed gene screening in CMT patients from Turkey

Sivaci M., Parman Y., Gonzaga-Jauregui C., Pehlivan D., Durmus H., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.21, pp.209, (Summary Text)

2014

51. Whole exome sequencing analysis in recessive hereditary spastic paraplegia patients from Turkey

Ozes B., Gonzalez M., Durmus H., Deymeer F., Oflazoglu P., Zuechner S., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

2014

52. Genotypic and phenotypic presentation of TTR-FAP in Turkey

Durmus H., Matur Z., Atmaca M. M., Poda M., Oflazer-Serdaroglu P., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.21, pp.137, (Summary Text)

2014

53. The distinct genetic pattern of ALS in Turkey

Ozoguz A., Uyan O., Birdal G., Iskender C., Omur O., Lahut S., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

2014

54. Clinical and genetic features of the patients with MNGIE: cohort at the department of neurology, Istanbul Faculty of Medicine

Cakar A., Durmus H., Gunduz T., Deymeer F., Parman Y., Oflazer-Serdaroglu P.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

2014

55. The distinct genetic pattern of ALS in Turkey

Ozoguz A., Uyan O., Birdal G., Iskender C., Omur O., Lahut S., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.21, pp.63, (Summary Text)

2014

56. Tafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantation

Matur Z., Atmaca M. M., Durmus H., Parman Y.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.21, pp.543, (Summary Text)

2014

57. Tafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantation

Matur Z., Atmaca M. M., Durmus H., Parman Y.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

2014

58. Genotype-Phenotype Evaluation In 476 Turkish Dystrophinopathy Patients

Durmuş H., GEYİK F., ERGINEL-UENALTUNA N., PODA M., Çakar A., Altınkaya A., et al.

The 66th AAN Annual Meeting, Philadelphia, United States Of America, 26 April 2014 - 03 May 0215, pp.96, (Full Text)

2013

59. Clinical and Genetic Characteristics of Five Turkish Families with UBQLN2 Mutations

Durmus H., Ozoguz A., Deymeer F., Serdaroglu P., Aysal F., Ertas M., et al.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, vol.80, (Summary Text)

2013

60. Distribution and Severity of Weakness in Patients with Polymyositis and Dermatomyositis: Different Pathophysiology, Different Affected Muscle Groups

Durmus H., Deymeer F., Parman Y., Serdaroglu P.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, vol.80, (Summary Text)

2012

61. IN-HOSPITAL STROKE RECURRENCE OF ACUTE ISCEMIC STROKE

Durmuş Tekçe H., Yeşilot N., Tuncay R., Çoban O., Zarkobahar S.

21.European Stroke Conference, Lisbon, Portugal, 22 - 24 May 2012, pp.651-652, (Summary Text)

2012

62. Using whole exome sequencing to identify the mutation causing oculopharyngodistal myopathy

Wagner M., Laval S., Mueller J., Durmus H., Serdaroglu-Oflazer P., Lochmueller H.

United Kingdom Neuromuscular Translational Research Conference, Newcastle-Upon-Tyne, United Kingdom, 22 - 23 March 2012, vol.22, (Summary Text)

2012

63. Clinical Features of the "Optineurin" Mutation in familial FTD and ALS

Cikrikcili U., Durmus H., Basak N., Gunel M., GÜRVİT İ. H., Matur Z., et al.

8th International Conference on Frontotemporal Dementias, Manchester, United Kingdom, 5 - 07 September 2012, vol.33, pp.231, (Summary Text)

2010

64. Oculopharyngodistal Myopathy Is a Distinct Entity - Clinical and Genetic Characterization of 40 Turkish OPDM Patients

Durmus H., Laval S. H., Deymeer F., Parman Y., Kiyan E., Gokyigit M., et al.

62nd Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 10 - 17 April 2010, (Summary Text)

2008

65. Anti-neuronal antibodies in Hashimoto's thyroiditis patients with central nervous system involvement

Durmuş H., Icoez S., Tuezuen E., Kuertuencue M., Hanagasi H. A., Bebek N., et al.

18th Meeting of the European-Neurological-Society, Nice, France, 7 - 11 June 2008, pp.139, (Summary Text)

2008

66. Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis: is it auto-immune?

KURTUNCU M., TUZUN E., ICOZ S., Baslo B., KAYA D., DURMUS H., et al.

18th Meeting of the European-Neurological-Society, Nice, France, 7 - 11 June 2008, vol.255, pp.216-217, (Summary Text)

2007

67. Demographic and clinical statistics of multiple sclerosis and demyelinating diseases in an outpatients clinic, Istanbul Faculty of Medicine

Kurtuncu M., Peldivan M., Durmus H., Mutlu M., Yesilot N., Korkmaz F., et al.

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Czech Republic, 11 - 14 October 2007

2007

68. Epileptic seizures in multiple sclerosis

Durmus H., Kurtuncu M., Matur Z., Pehlivan M., Mutlu M., Yapici Z., et al.

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Czech Republic, 11 - 14 October 2007, vol.13

2007

69. Devic's neuromyelitis optica: a prospective study

Eraksoy M., Akman-Demir G., Kurtuncu M., Yapici Z., Mutlu M., Topcular B., et al.

17th Meeting of the European-Neurological-Society, Rhodes, Greece, 16 - 20 June 2007, pp.36

2007

70. The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up

Eraksoy M., Akinan-Demir G., Yapici Z., Kurtuncu M., Mutlu M., Topcular B., et al.

17th Meeting of the European-Neurological-Society, Rhodes, Greece, 16 - 20 June 2007, pp.39

Books

2020

1. Familial Amiloid Polinöropati - Dünya ve Türkiye Deneyimi Yeni Gelişmeler Işığında Transtiretin İlişkili Ailevi Amiloid Polinöropatisi

ÇAKAR A., DURMUŞ TEKÇE H., DEYMEER F., OFLAZER P., PARMAN F. Y.

in: Nadir Hastalıklar Pompe, Fabry ve TTR-FAP, Hilmi Uysal, Editor, Palme Yayınevi, Ankara, pp.177-190, 2020

2015

2. Konjenital Miyopatiler

DURMUŞ TEKÇE H.

in: ÇOCUK VE ERGENDE NÖROLOJİK HASTALIKLARA YAKLAŞIMREHBER KİTABI, Ayşın DerventSemih AytaÖzlem ÇokarDerya Uludüz, Editor, Türk Nöroloji Derneği, pp.259-262, 2015

2015

3. Juvenil Myastenia Gravis

DURMUŞ TEKÇE H., DEYMEER F.

in: ÇOCUK VE ERGENDE NÖROLOJİK HASTALIKLARAYAKLAŞIM REHBER KİTABI, Ayşın DerventSemih AytaÖzlem ÇokarDerya Uludüz, Editor, Türk Nöroloji Derneği, pp.320-324, 2015

Funded Projects

2019 - 2023

Kontraktürle seyreden nöromüsküler hastalıklara neden olabilecek yeni genlerin araştırılması: Genom ve Tüm Ekzom Çalışması

Project Supported by Higher Education Institutions , BAP Research Project

DURMUŞ TEKÇE H. (Executive), YUNISOVA G., PARMAN F. Y.

2018 - 2019

Kontraktürlü Miyopatilerin Klinik ve Genetik Özelliklerinin Belirlenmesi

Project Supported by Higher Education Institutions , BAP PhD

DURMUŞ TEKÇE H. (Executive), YUNISOVA G., PARMAN F. Y.

2017 - 2017

Cytokine Production in Myasthenia Gravis Patients

Project Supported by Higher Education Institutions , BAP Other

YILMAZ V. (Executive), DEYMEER F., OFLAZER P., SARUHAN DİRESKENELİ G., DURMUŞ TEKÇE H., TÜZÜN E., et al.

2017 - 2017

32 novel pathogenic sequence variants in 253 DMD/BMD patients from Turkey

Project Supported by Higher Education Institutions , BAP Other

TOKSOY G. (Executive), BAGİROVA G., ALTUNOĞLU U., PARMAN F. Y., UYGUNER Z. O., OFLAZER Z. P., et al.

2016 - 2017

Myasthenia gravisde otoantikor üretimini düzenleyen mekanizmaların periferik kan ve timus B hücrelerinde incelenmesi

Project Supported by Higher Education Institutions , BAP Other

SARUHAN DİRESKENELİ G. (Executive), DURMUŞ TEKÇE H., HOCAOĞLU M., ALTINTAŞ F.

2016 - 2017

Kasa Özgü Kinaza Karşı Otoantikorlarla Gelişen Myasthenia Gravis (MuSK-MG) de HLA İlişkisinin Otoantikor İzotiplerine Etkisi

Project Supported by Higher Education Institutions , BAP MSc

SARUHAN DİRESKENELİ G. (Executive), ÇEBİ M., DURMUŞ TEKÇE H.

2016 - 2016

Myasthenia gravis'de CD4 efektör ve regulatör T hücre ortak kültürlerinde sitokin üretimi ve IL-21'in etkisi

Project Supported by Higher Education Institutions , BAP Other

SARUHAN DİRESKENELİ G. (Executive), DURMUŞ TEKÇE H.

2013 - 2015